Table 2.
HY | HO | ||
---|---|---|---|
MRS measurement | GABA+ | 1.05 ± 0.17 | 0.94 ± 0.17 |
N = 38 | N = 105 | ||
GABA+/ tCr | 0.15 ± 0.025 | 0.12 ± 0.025 | |
N = 38 | N = 105 | ||
tCr | 7.25 ± 0.50 | 7.73 ± 0.79 | |
N = 38 | N = 105 | ||
mI | 6.38 ± 0.65 | 7.60 ± 1.15 | |
N = 38 | N = 105 | ||
mI/tCr | 0.89 ± 0.08 | 0.98 ± 0.11 | |
N = 38 | N = 105 | ||
tCho | 1.80 ± 0.17 | 2.10 ± 0.35 | |
N = 38 | N = 105 | ||
tCho/tCr | 0.248 ± 0.022 | 0.268 ± 0.035 | |
N = 38 | N = 105 | ||
tNAA | 9.66 ± 0.83 | 9.75 ± 1.24 | |
N = 38 | N = 105 | ||
tNAA/tCr | 1.34 ± 0.11 | 1.30 ± 0.15 | |
N = 38 | N = 105 | ||
Glu+Gln (Glx) | 9.33 ± 1.30 | 8.74 ± 1.04 | |
N = 40 | N = 105 | ||
Glx/tCr | 1.28 ± 0.36 | 1.18 ± 0.43 | |
N = 40 | N = 105 | ||
MRS voxel tissue fraction | GM | 0.51 ± 0.03 | 0.44 ± 0.04 |
N = 40 | N = 105 | ||
WM | 0.36 ± 0.04 | 0.36 ± 0.06 | |
N = 40 | N = 105 | ||
CSF | 0.14 ± 0.03 | 0.19 ± 0.05 | |
N = 40 | N = 105 |